Antimicrobial use and risk for recurrent clostridium difficile infection

American Journal of Medicine

Volumn 124, Issue 11, 2011, Pages

  Drekonja, Dimitri M ^a,b   Amundson, William H ^c   Decarolis, Douglas D ^a,b   Kuskowski, Michael A ^a,b   Lederle, Frank A ^a,b   Johnson, James R ^a,b  

^a Minneapolis Veterans Affairs Health Care System   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Antimicrobial use; Clostridium difficile infection; Recurrent CDI

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTACID AGENT; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; BETA LACTAM; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; COTRIMOXAZOLE; HISTAMINE H2 RECEPTOR ANTAGONIST; IMMUNOSUPPRESSIVE AGENT; LINEZOLID; MACROLIDE; METRONIDAZOLE; NITROFURANTOIN; PROTON PUMP INHIBITOR; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TETRACYCLINE DERIVATIVE; VANCOMYCIN;

AGED; ANTIMICROBIAL THERAPY; ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; DISEASE SEVERITY; DRUG USE; FEMALE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; RECURRENT INFECTION; RETROSPECTIVE STUDY; TREATMENT DURATION;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; FOLLOW-UP STUDIES; HOSPITALS, VETERANS; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; MINNESOTA; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; VANCOMYCIN;

EID: 80054976907     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2011.05.032     Document Type: Article

References (30)

1. J. Pepin, L. Valiquette, and B. Cossette Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec CMAJ 173 9 2005 1037 1042
2. L.C. McDonald, G.E. Killgore, and A. Thompson An epidemic, toxin gene-variant strain of Clostridium difficile N Engl J Med 353 23 2005 2433 2441 (Pubitemid 41770164)
3. F. Barbut, P. Mastrantonio, and M. Delmee Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterisation of the isolates Clin Microbiol Infect 13 11 2007 1048 1057 (Pubitemid 47553515)
4. D.N. Gerding, C.A. Muto, and R.C. Owens Jr Treatment of Clostridium difficile infection Clin Infect Dis 46 Suppl 1 2008 S32 S42
5. D.N. Gerding, M.M. Olson, and L.R. Peterson Clostridium difficile-associated diarrhea and colitis in adults A prospective case-controlled epidemiologic study Arch Intern Med 146 1 1986 95 100 (Pubitemid 16158635)
6. R. Fekety, and A.B. Shah Diagnosis and treatment of Clostridium difficile colitis JAMA 269 1 1993 71 75 (Pubitemid 23006526)
7. A. Sullivan, C. Edlund, and C.E. Nord Effect of antimicrobial agents on the ecological balance of human microflora Lancet Infect Dis 1 2 2001 101 114 (Pubitemid 33586045)
8. M.M. Olson, C.J. Shanholtzer, J.T. Lee Jr, and D.N. Gerding Ten years of prospective Clostridium difficile-associated disease surveillance and treatment at the Minneapolis VA Medical Center, 1982-1991 Infect Control Hosp Epidemiol 15 6 1994 371 381
9. D.G. Teasley, D.N. Gerding, and M.M. Olson Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis Lancet 2 8358 1983 1043 1046 (Pubitemid 14235361)
10. S.H. Cohen, D.N. Gerding, and S. Johnson Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA) Infect Control Hosp Epidemiol 31 5 2010 431 455
11. S. Nair, D. Yadav, M. Corpuz, and C.S. Pitchumoni Clostridium difficile colitis: factors influencing treatment failure and relapsea prospective evaluation Am J Gastroenterol 93 10 1998 1873 1876 (Pubitemid 29071697)
12. R. Fekety, L.V. McFarland, and C.M. Surawicz Recurrent Clostridium difficile diarrhea: characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial Clin Infect Dis 24 3 1997 324 333 (Pubitemid 27096783)
13. M.Y. Hu, K. Katchar, and L. Kyne Prospective derivation and validation of a clinical prediction rule for recurrent Clostridium difficile infection Gastroenterology 136 4 2009 1206 1214
14. S. Aslam, R.J. Hamill, and D.M. Musher Treatment of Clostridium difficile-associated disease: old therapies and new strategies Lancet Infect Dis 5 9 2005 549 557 (Pubitemid 41196754)
15. R. Fekety Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis American College of Gastroenterology, Practice Parameters Committee Am J Gastroenterol 92 5 1997 739 750
16. L.C. McDonald, B. Coignard, and E. Dubberke Recommendations for surveillance of Clostridium difficile-associated disease Infect Control Hosp Epidemiol 28 2 2007 140 145 (Pubitemid 46374153)
17. C.P. Kelly, C. Pothoulakis, and J.T. LaMont Clostridium difficile colitis N Engl J Med 330 4 1994 257 262 (Pubitemid 24034138)
18. S.D. Horn, P.D. Sharkey, and D.A. Bertram Measuring severity of illness: homogeneous case mix groups Med Care 21 1 1983 14 30 (Pubitemid 13154822)
19. A. Berrington Antimicrobial prescribing in hospitals: be careful what you measure J Antimicrob Chemother 65 1 2009 163 168
20. I. Lowy, D.C. Molrine, and B.A. Leav Treatment with monoclonal antibodies against Clostridium difficile toxins N Engl J Med 362 3 2010 197 205
21. R. McCarney, J. Warner, and S. Iliffe The Hawthorne Effect: a randomised, controlled trial BMC Med Res Methodol 7 2007 30
22. A. Linsky, K. Gupta, and E.V. Lawler Proton pump inhibitors and risk for recurrent Clostridium difficile infection Arch Intern Med 170 9 2010 772 778
23. V.G. Loo, L. Poirier, and M.A. Miller A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality N Engl J Med 353 23 2005 2442 2449 (Pubitemid 41770165)
24. S.G. Vanderweil, C.L. Tsai, and A.J. Pelletier Inappropriate use of antibiotics for acute asthma in United States emergency departments Acad Emerg Med 15 8 2008 736 743
25. P.M. Polgreen, Y.Y. Chen, and J.E. Cavanaugh An outbreak of severe Clostridium difficile-associated disease possibly related to inappropriate antimicrobial therapy for community-acquired pneumonia Infect Control Hosp Epidemiol 28 2 2007 212 214 (Pubitemid 46374165)
26. R. Mangione-Smith, L. Wong, and M.N. Elliott Measuring the quality of antibiotic prescribing for upper respiratory infections and bronchitis in 5 US health plans Arch Pediatr Adolesc Med 159 8 2005 751 757 (Pubitemid 41126839)
27. R. Gonzales, C.A. Camargo Jr, and T. MacKenzie Antibiotic treatment of acute respiratory infections in acute care settings Acad Emerg Med 13 3 2006 288 294
28. D.M. Drekonja, N.C. Okoye, M.A. Kuskowski, and J.R. Johnson Appropriateness of urinary tract infection diagnosis and treatment duration Arch Intern Med 170 5 2010 489 490
29. M. Cope, M.E. Cevallos, and R.M. Cadle Inappropriate treatment of catheter-associated asymptomatic bacteriuria in a tertiary care hospital Clin Infect Dis 48 9 2009 1182 1188
30. J.F. Steiner, and A.V. Prochazka The assessment of refill compliance using pharmacy records: methods, validity, and applications J Clin Epidemiol 50 1 1997 105 116 (Pubitemid 27089212)